Literature DB >> 31085180

CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.

Michael A Augello, Deli Liu, Lesa D Deonarine, Brian D Robinson, Dennis Huang, Suzan Stelloo, Mirjam Blattner, Ashley S Doane, Elissa W P Wong, Yu Chen, Mark A Rubin, Himisha Beltran, Olivier Elemento, Andries M Bergman, Wilbert Zwart, Andrea Sboner, Noah Dephoure, Christopher E Barbieri.   

Abstract

Entities:  

Year:  2019        PMID： 31085180     DOI： 10.1016/j.ccell.2019.04.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  14 in total

Review 1.  Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.

Authors:  Andrea K Miyahira; Adam Sharp; Leigh Ellis; Jennifer Jones; Salma Kaochar; H Benjamin Larman; David A Quigley; Huihui Ye; Jonathan W Simons; Kenneth J Pienta; Howard R Soule
Journal:  Prostate       Date:  2019-12-11       Impact factor: 4.104

2.  Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.

Authors:  Di Zhao; Li Cai; Xin Lu; Xin Liang; Jiexi Li; Peiwen Chen; Michael Ittmann; Xiaoying Shang; Shan Jiang; Haoyan Li; Chenling Meng; Ivonne Flores; Jian H Song; James W Horner; Zhengdao Lan; Chang-Jiun Wu; Jun Li; Qing Chang; Ko-Chien Chen; Guocan Wang; Pingna Deng; Denise J Spring; Y Alan Wang; Ronald A DePinho
Journal:  Cancer Discov       Date:  2020-05-08       Impact factor: 39.397

3.  CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.

Authors:  Haoyan Li; Yin Wang; Kevin Lin; Varadha Balaji Venkadakrishnan; Martin Bakht; Wei Shi; Chenling Meng; Jie Zhang; Kaitlyn Tremble; Xin Liang; Jian H Song; Xu Feng; Vivien Van; Pingna Deng; Jared K Burks; Ana Aparicio; Khandan Keyomarsi; Junjie Chen; Yue Lu; Himisha Beltran; Di Zhao
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

4.  Anastrozole Regulates Fatty Acid Synthase in Breast Cancer.

Authors:  Junmei Cairns; James N Ingle; Krishna R Kalari; Matthew P Goetz; Richard M Weinshilboum; Huanyao Gao; Hu Li; Mehrab Ghanat Bari; Liewei Wang
Journal:  Mol Cancer Ther       Date:  2021-10-19       Impact factor: 6.009

5.  Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction.

Authors:  Xia Liu; Changfa Sun; Kexin Zou; Cheng Li; Xiaojun Chen; Hangchao Gu; Zhiyang Zhou; Zuwei Yang; Yaoyao Tu; Ningxin Qin; Yiran Zhao; Yimei Wu; Yicong Meng; Guolian Ding; Xinmei Liu; Jianzhong Sheng; Chuanjin Yu; Hefeng Huang
Journal:  EBioMedicine       Date:  2020-10-21       Impact factor: 8.143

6.  A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.

Authors:  Han Chen; Han Liang
Journal:  Cancer Cell       Date:  2020-10-01       Impact factor: 31.743

7.  MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.

Authors:  Leah C Rider; Lindsey U Rodrigues; Lauren K Jillson; Lina Romero; Anis Karimpour-Fard; Cera Nieto; Claire Gillette; Kathleen Torkko; Etienne Danis; Elizabeth E Smith; Rosalie Nolley; Donna M Peehl; M Scott Lucia; James C Costello; Scott D Cramer
Journal:  Mol Cancer Res       Date:  2021-04-12       Impact factor: 5.852

Review 8.  Epidemiology and genomics of prostate cancer in Asian men.

Authors:  Yao Zhu; Miao Mo; Yu Wei; Junlong Wu; Jian Pan; Stephen J Freedland; Ying Zheng; Dingwei Ye
Journal:  Nat Rev Urol       Date:  2021-03-10       Impact factor: 14.432

Review 9.  Sophisticated Conversations between Chromatin and Chromatin Remodelers, and Dissonances in Cancer.

Authors:  Cedric R Clapier
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

10.  Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.

Authors:  Zeda Zhang; Chuanli Zhou; Xiaoling Li; Spencer D Barnes; Su Deng; Elizabeth Hoover; Chi-Chao Chen; Young Sun Lee; Yanxiao Zhang; Choushi Wang; Lauren A Metang; Chao Wu; Carla Rodriguez Tirado; Nickolas A Johnson; John Wongvipat; Kristina Navrazhina; Zhen Cao; Danielle Choi; Chun-Hao Huang; Eliot Linton; Xiaoping Chen; Yupu Liang; Christopher E Mason; Elisa de Stanchina; Wassim Abida; Amaia Lujambio; Sheng Li; Scott W Lowe; Joshua T Mendell; Venkat S Malladi; Charles L Sawyers; Ping Mu
Journal:  Cancer Cell       Date:  2020-03-26       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.